Skip to main content

Advertisement

We’d like to understand how you use our websites in order to improve them. Register your interest.
Download PDF

Lifestyle medicine for depression

BMC Psychiatry volume 14, Article number: 107 (2014) Cite this article

Abstract

The prevalence of depression appears to have increased over the past three decades. While this may be an artefact of diagnostic practices, it is likely that there are factors about modernity that are contributing to this rise. There is now compelling evidence that a range of lifestyle factors are involved in the pathogenesis of depression. Many of these factors can potentially be modified, yet they receive little consideration in the contemporary treatment of depression, where medication and psychological intervention remain the first line treatments. “Lifestyle Medicine” provides a nexus between public health promotion and clinical treatments, involving the application of environmental, behavioural, and psychological principles to enhance physical and mental wellbeing. This may also provide opportunities for general health promotion and potential prevention of depression. In this paper we provide a narrative discussion of the major components of Lifestyle Medicine, consisting of the evidence-based adoption of physical activity or exercise, dietary modification, adequate relaxation/sleep and social interaction, use of mindfulness-based meditation techniques, and the reduction of recreational substances such as nicotine, drugs, and alcohol. We also discuss other potential lifestyle factors that have a more nascent evidence base, such as environmental issues (e.g. urbanisation, and exposure to air, water, noise, and chemical pollution), and the increasing human interface with technology. Clinical considerations are also outlined. While data supports that some of these individual elements are modifiers of overall mental health, and in many cases depression, rigorous research needs to address the long-term application of Lifestyle Medicine for depression prevention and management. Critically, studies exploring lifestyle modification involving multiple lifestyle elements are needed. While the judicious use of medication and psychological techniques are still advocated, due to the complexity of human illness/wellbeing, the emerging evidence encourages a more integrative approach for depression, and an acknowledgment that lifestyle modification should be a routine part of treatment and preventative efforts.

Peer Review reports

Introduction

While modernity has provided multiple technological and medical advances including increased life-expectancy, it has come at a cost, in that a range of lifestyle issues are now negatively affecting our mental health [1]. As Hidaka [1] and Walsh [2] comment, in Western society people are increasingly becoming more sedentary and eating a poorer diet than previous generations. This, in combination with sleep/wake cycle pressures, substance misuse, and psychosocial factors such as more competition and time pressure, social isolation and less intimate engagement with the family unit, may exert a cost on mental health. Further, the combination of stress, fatigue, inactivity, and sleep deficiency in people who are “time-poor”, may advance obesity, and this in turn may promote a sedentary life with potential for resultant depression.

Due to the afore-mentioned challenges of modern urbanity, there is now the need to consider a “Lifestyle Medicine” approach for the potential prevention, promotion and management of depression. While medication and psychological interventions are first-line treatments for depression, Lifestyle Medicine offers a potentially safe and low-cost option for augmenting the management of the condition. While the evidence base remains patchy, many lifestyle or environmental factors are mutable and can provide the basis of practical interventions for the management of depression (summarised in Table 1). Lifestyle Medicine involves the application of environmental, behavioural, and psychological principles to enhance physical and mental wellbeing, adding a therapeutic and potentially preventative approach to illness [3]. This may involve modification of: diet; physical activity and exercise; relaxation and sleep-wake cycles; recreation and work-rest balance; and minimisation/avoidance of smoking, alcohol or illicit substances, in addition to the use of mindfulness-based meditation techniques [2]. Although the evidence base remains in its infancy, environmental issues are also considerations, such as reducing exposure to pollution (air, water, noise, and chemicals) and increasing time spent in nature, and are areas of current investigation. Activity scheduling such as encouraging engagement in meaningful activities and adequate social contact [1] is additionally of value. Further, Lifestyle Medicine may involve the application of clinical psychological techniques, insofar as motivational and behavioural factors are intrinsic to people trying to embrace lifestyle changes [3].

Table 1 Lifestyle medicine for depression
Full size table

While lifestyle modification has been recognised by practitioners for centuries as a means by which to improve health outcomes, the field of “Lifestyle Medicine”, particularly in the context of mental health, is a relatively new field. While papers have discussed its broader application on health and in particular prevention of chronic disease and cardiovascular/metabolic conditions, little attention has been given to its application for mental health, and in particular depression, which is predicted to be the predominant cause of disability in the developed world [4], and is being argued as one of the prevalent non-communicable disorders [5]. Some studies show that patients with sub-threshold depression rate lifestyle or psychosocial approaches as strategies that are most helpful in improving their mood [6], while patients with clinical depression have rated exercise as the most effective intervention [7].

There is a heuristic theoretical framework explaining why the modern lifestyle may be impacting mental health. Obesity [8], poor diet [9], poor/decreased sleep [10], exposure to chemicals and pollutants [11], and high stress levels [12], may potentially disrupt the hypothalamic pituitary adrenal axis, increase cortisol and increase low-grade systemic inflammation and oxidative stress. Both neuroendocrine disruption and inflammation have been linked to the aetiology of depression [13, 14]. Specifically, increased levels of proinflammatory cytokines, interferon gamma and neopterin, reactive oxygen and nitrogen species and damage by oxidative and nitrosative stress, in combination with lowered levels of antioxidants, may potentially damage mitochondria and mitochondrial DNA; this may result in neurodegeneration and reduced neurogenesis [14].

This opinion paper aims to provide a context for Lifestyle Medicine by providing an overview of the lifestyle factors that are linked with depression risk before exploring the evidence and clinical application of modifying these elements. The paper firstly explores data for which there is sound evidentiary support (diet, physical activity and exercise, mindfulness meditation, management of recreational substance misuse, sleep, and social interaction), and then touches on lifestyle and environmental elements that have nascent data and are subject to confirmatory investigation (greenspace and pollutant exposure, hobbies and relaxation, and animal/pet therapy).

Review

Lifestyle elements with supportive data

Diet

Major dietary changes have occurred across the globe in the past century [15]. Specifically, there has been a shift in the common dietary patterns of Western societies to typically include high levels of energy, saturated fats and refined sugar. In fact, nutrient-insufficient and energy-dense foods now contribute approximately 30% to the daily dietary intakes of American adults [16]. Over recent years, evidence has emerged to suggest that poor diet may be a risk factor for the onset of depression. While the strength and nature of this relationship remains unclear, not only have cross-sectional data shown that poor dietary patterns and quality are associated with depressed mood and anxiety [9, 17–25], but prospective studies have further provided support for the predictive role of diet in the development of mental disorders.

Recent prospective data from the ongoing Whitehall II cohort study of middle-aged office workers in Britain (n = 3486) has revealed an increased risk of incident depression over five years for people consuming a Western style dietary pattern. Moreover, a reduced risk for those eating a whole foods diet pattern was observed [26]. Another recent prospective study, this time comprising Australian adolescents, has provided comparable data. An examination of examined 3040 Australian adolescents (aged 11–18) found that diet quality was associated with adolescent mental health both cross-sectionally and prospectively [27], where deterioration in diet quality was associated with poorer psychological functioning. Importantly, improvements in mental health were also mirrored by improvements in diet quality.

The notion that dietary modification can result in improved mental health outcomes is further supported by data from a large European study. The Spanish SUN Cohort study demonstrated an inverse association between the level of adherence to a Mediterranean dietary pattern and the risk for incident depression over approximately four years in more than 10,000 middle-aged professionals [28]. Importantly, these data did not support the reverse causality hypothesis -that depression causes poor dietary choices. Coupled with significant findings observed in other studies conducted around the world (Korea, Greece), these findings suggest a consistent pattern for the association between diet and mental health in various settings [29, 30]. However, the issue of heterogeneity amongst studies is noted [31].

While the mechanisms underpinning the association between diet and mental health are not fully understood, various pathways have been proposed. Diet modulates several key biological processes that underscore mood disorders, including brain plasticity and function, the stress response system, mitochondria, inflammation, and oxidative processes [32, 33]. A Western dietary pattern is associated with increased markers of systemic inflammation [34]. Further, an aetiological role for inflammation in the pathophysiology of depression is suggested by recent data showing that higher levels of serum high-sensitivity C-reactive protein (a marker of systemic inflammation) is an independent risk factor for a depressive episode [35]. Among people suffering from depression, systemic immune activation, characterised by increased levels of pro-inflammatory cytokines [36, 37] and alterations in the acute phase protein response [38], have been observed. Another aspect of consideration, is that a wholefood diet provides protein and essential fatty acids, in addition to a range of micronutrients that are critical in neurochemical function, including B vitamins, zinc, magnesium, vitamin C, and a range of plant compounds such as flavonoids that are potent antioxidants and anti-inflammatories [39–41].

Altering dietary patterns may affect a variety of factors influencing the development and trajectory of depression [42]. While epidemiological data appear persuasive, currently no robust study has been conducted exploring the therapeutic impact of dietary changes on any diagnosed mental illness. Recent encouraging data suggests that dietary modification can reduce the risk of cardiovascular disease [34]. There are encouraging signs in a pilot randomised controlled study by McMillan et al. [43] that evaluated the effects of dietary change on mood and cognition in healthy individuals. The study examined 10 days of adherence to a nutrient-rich diet, compared to no dietary change in 25 young female adults. The dietary change group showed significant improvements in self-rated vigour, alertness and contentment compared to the control group. Other studies comprising depressed populations have demonstrated the benefits of dietary modification using supplements such as omega 3 polyunsaturated fatty acid (PUFAs) on mood outcomes. Recent meta-analyses [44–46] have highlighted the benefits of PUFAs (in particular eicosapentaenoic acid) in those with depression; specifically, for those with greater symptom severity. However, high heterogeneity of the studies was observed.

While these emerging data provide potential validity for the role of dietary and nutritional factors in the genesis of depression and its management, it should be acknowledged that currently, there is minimal evidence for dietary modulation as a treatment for depression. A current clinical trial [47] is however underway to test this hypothesis by assessing the effect of a prescriptive diet versus an inactive control (befriending). The results of the RCT are due in 2015. Regardless of the current deficit of empirical evidence for prescriptive dietary advice to treat depression, it is recognized that diet has a major impact on comorbid medical conditions that are exceedingly more common in people diagnosed with depression, including cardiovascular disease and metabolic disorders [48], and the precautionary principle should guide practice.

Physical activity and exercise

Modernity has similarly reduced the amount of work- and leisure-time physical activity (PA) and formalized exercise undertaken by the average person. Our lifestyles are increasingly sedentary, with the resultant side-effect of obesity currently recognized as a major health problem worldwide [49, 50]. Epidemiological studies have shown that adequate PA (based on clinical guidelines) is associated with fewer depressive symptoms, while insufficient PA may be a risk factor for the development of depressive symptoms [51–54]. This risk factor may be best modified in early development, [55] as regular PA in childhood is associated with reduced risk of developing depression in adulthood. This effect was found even after adjusting for adult PA. Pasco et al. [56] also showed a similar protective effect of PA in the elderly. Not all studies have found such as association: a longitudinal analysis (1991–2002) of the effects of exercise on depressive symptoms among 5952 genetically identical twins (aged 18–50) showed that an increase in exercise participation did not predict fewer depressive symptoms [57].

Aside from general PA having a potential relationship with mental health, formalised exercise appears to be an effective mood elevator [58–60]. Exercise is also a relatively cheap and safe intervention that has been shown to provide a range of additional health benefits [61]. Aside from exercise providing marked beneficial effects on neuroendocrine systems, it also increases self-efficacy and self-esteem (via activity scheduling and attainment of goals) which are important psychological issues among people who are depressed [62]. Furthermore, exercise may have additional beneficial effects by increasing social engagement and enhancing body image.

Exercise has been shown to moderate a range of biological pathways including: inflammatory cytokines, oxidative stress, neurotrophins and neurogenesis [32, 63]. In animal models, exercise has demonstrated biological effects via multiple mechanisms, including increased levels of brain derived neurotropic factor (BDNF) [64, 65], and enhanced neurogenesis [66]. Modulation of monoamine systems has also been shown, with PA increasing expression of 5HT in animal models [67], and this is theorised to explain some of the antidepressant effect of exercise [60]. The long-term chronic effects of regular exercise may assist in regulating the neuroendocrine axis and produce a normalisation of cortisol levels [68], while increasing circulating beta–endorphins [69] (for a review see Moylan et al. 2013) [70].

Evidence provides some support for the use of exercise. A recent Cochrane review (updated from 2009) included 32 studies (n = 1858) involving exercise for the treatment of researcher-defined depression [71]. From these studies, 28 RCTs (n = 1101) were included in a meta-analysis revealing a moderate to large effect in favour of exercise over standard treatment or control. However, only four trials (n = 326) with adequate allocation concealment, blinding and ITT analysis were located, resulting in a more modest effect size in favour of exercise. Pooled data from seven trials (n = 373) with long-term follow-up data also found a small clinical effect in favour of exercise.

Adequate PA and exercise is of synergistic relevance given the increased burden of obesity and the metabolic syndrome in individuals with psychiatric disorders [48], and the well-established benefits of PA in those comorbid health conditions. Currently, the balance of evidence supports the use of exercise of adequate intensity and duration to improve mood and reduce depressive symptoms and comorbid medical disorders.

Another form of exercise that combines a “mindfulness” element (discussed further below), is the practice of yoga. A recent systematic review located 12 RCTs (pooled n = 619) [72]. For effect on the severity of depression, there was moderate evidence showing a beneficial short-term effect of yoga compared to usual care, and limited evidence compared to relaxation, and aerobic exercise. Aside from the physiological benefits from yoga, the mindfulness component may also provide a form of focus that may quell rumination (which is common in depression). It should be noted that while yoga is gaining increased popularity in the Western world, its safety needs to be considered. While Yoga is regarded as generally safe, a previous review has revealed 76 cases of adverse events from its practice [73]. Due to this, yoga should be practiced carefully under the guidance of a qualified instructor.

Mindfulness meditation

Meditative practices may also have an application in improving mood and preventing the tumescence of a depressive episode. While the concept of meditation is varied, it can be categorized into “open monitoring” or “focused” forms. A key aspect of meditative practice involves mindfulness, commonly defined as the awareness which arises through “paying attention in a particular way: on purpose, in the present moment, and non-judgmentally” [74]. The use of meditation as a Western behavioral intervention was pioneered by Kabat-Zinn [75], with the formal training program known as Mindfulness-Based Stress Reduction (MBSR). The practice of MBSR is centered on an 8–10 week structured program which involves (a) training in mindfulness meditation practice, (b) mindful awareness e.g. during yoga postures, and (c) mindfulness during stressful everyday situations and social interaction. Meditative practices such as MBSR can be readily incorporated into people’s lives, and requires only basic training (although more advanced traditional techniques, or modern techniques involving CBT, can also be taught).

Regular meditation has been shown in various neuroimaging studies to affect a range of biological changes such as, alterations in gray matter morphology, increased cortical thickness in the prefrontal cortex (PFC) and right anterior insula, increased oxygenated haemoglobin in the anterior PFC, and elevations in whole blood serotonin (5-HT) levels [76, 77]. Electroencephalographic (EEG) studies have revealed a significant increase in alpha and theta activity during meditation [78]. Evidence supporting mindfulness is growing, with a review and meta-analysis of the intervention for anxiety and mood reduction revealing a large effect size on improving mood symptoms for participants receiving mindfulness-based training [79]. It should be noted that the quality of most studies are poor, and it is often difficult to ascertain which form/s of meditation is more appropriate for use in depression.

Management of recreational substances (alcohol, cigarettes, caffeine)

Epidemiological studies and community surveys indicate that alcohol abuse and dependence commonly co-occur with affective disorders. Although the specific mechanisms of the associations are still being elucidated [80], acute alcohol use increases release of monoamines [81]. While acute alcohol use reduces neuronal glutamate release, during alcohol withdrawal (colloquially known as the “hangover” stage) a greater amount of rebound glutamate is released from the synapses and in combination with dysregulated monoamine and neuroendocrine pathways, may provoke anxiety and dysphoria [81]. A meta-analysis of four large-scale epidemiological studies found a two- to three fold increased lifetime risk for both depressive and anxiety disorders in those with alcohol dependence or abuse [80]. This has been further supported by a more recent meta-analysis which found that the presence of either an alcohol use disorder or major depressive disorder doubles the risk of the other disorder [82]. There is also data from prospective community studies that shows heavy use of alcohol in adolescence and young adulthood predicts later onset of major depressive disorder [83]. Further, harmful or hazardous alcohol use (defined by ICD-10 criteria) when compared with light drinkers in early adulthood predicts greater depressive symptomatology, even after controlling for confounding factors [84]. Several studies have shown that depressed mood is substantially alleviated within a very short time after abstaining from alcohol [85–87]. A study of 235 women with postpartum depression who were consuming above recommended levels of alcohol, found a brief alcohol intervention (two clinician-guided sessions providing safe drinking guidance and homework tasks), to be effective at reducing depressive symptoms (compared with no treatment intervention) at six-months following the intervention [88].

Smoking cigarettes increases the risk for the genesis of affective and anxiety disorders [89–93] and appears to be a potential risk factor for the development of de-novo depression [94]. Cigarette smoking in adolescence may also increase the risk of the later development of clinically significant depressive symptoms [95]. There is a risk of escalation of smoking in people with depression [91], with some evidence for the existence of a shared genetic vulnerability to both smoking and depression [96]. In both unipolar depression and bipolar disorder (but perhaps not schizophrenia), smoking has not only a deleterious effect on symptom severity [97], but may also interfere with response to treatment [98, 99]. A greater risk of continued smoking and lower abstinence rates may also be associated with sub-threshold depressive symptoms [100]. Smoking for some may be a form of self-medication for acute dysphoric symptom reduction [91, 101]. Regular smokers can be viewed as being in a persistent dysphoric withdrawal state, punctuated by brief intoxications when ingesting nicotine. A key neurobiological mechanism linking smoking and mood involves the dopaminergic system, which is implicated in addiction. Aside from involvement in the regulation of mood, dopamine has a crucial role in the reward/addiction pathways [102]. As mentioned above, depression can be seen as having an inflammatory component, and smoking also aggravates inflammation and provokes marked oxidative stress [103]. Additionally, evidence from a cross-sectional study indicates that second-hand cigarette smoke is positively associated with depressive symptoms in smoking-naive people (even after adjustment for age, race/ethnicity, gender, education, alcohol consumption, and medical comorbidities) [104].

Caffeine is in many cultures the most commonly used psychoactive substance. It acutely increases attention, alertness, cognition and mood, with some individuals with dysphoric mood being predisposed to use caffeine more heavily, due to its mood-elevating potential (via activation of noradrenergic and dopaminergic pathways) [105]. Caffeine modulates the adenosine system, and the anxiogenic potential of caffeine is influenced by polymorphisms of the A2A receptor [106]. There is a suggestion of dysregulation of the adenosine system in depression [107]. While evidence supports the avoidance of caffeine in anxiety disorders [108], data suggests that caffeine use from coffee consumption may be protective against depression. A prospective longitudinal analysis (1996–2006) of 50,739 US women (mean age, 63 years) who were free of depressive symptoms at baseline, found that there was a reduced risk of diagnosed depression at follow up for those consuming two to three cups per day compared to those consuming one or less per week [109]. This effect was even slightly stronger in those consuming over four cups per day. Interestingly, decaffeinated coffee was not associated with depression risk. Regardless, there is the potential for people with high caffeine use affecting insomnia, and this in turn may increase risk or aggravation of depressed mood [110]. High caffeine containing energy drinks are increasingly popular, and there is a suggestion, albeit methodologically preliminary, of an association of use with mood disorders [111–113].

Sleep

A good night’s sleep is critical for mental and physical health, and affective disorders are associated with major disturbance in circadian rhythm [114, 115]. Sleep disturbance is a frequent symptom of depression, and a strong causal link exists between insomnia and depression [116]. Further, residual sleep difficulties may be predictive of subsequent depression relapse. It is likely that this is bidirectional; that is, insomnia can increase depression risk and vice versa. Research has shown that people with chronic insomnia have an increased risk of a major depressive disorder. Cross-sectional data of 2,619 individuals from the Netherlands Study of Depression and Anxiety (NESDA) revealed that people with a current depressive or anxiety disorder, or remittent depression had a significant association with sleep disturbance. Interestingly, sociodemographic factors and psychotropic medication use was not found to contribute to sleep outcomes [117]. A review of 21 prospective studies with follow-up data by Baglioni [118] found that insomnia predicted two-fold increased risk for a depressive episode. Epidemiological data have shown that approximately 40% of chronic insomniacs suffer from another comorbid psychiatric disorder [10]. Aside from poor sleep affecting mood, data from the Behavioral Risk Factor Surveillance System of 138,201 individuals found that sleep disturbance is a significant risk factor for myocardial infarction, stroke, obesity, diabetes, and coronary artery disease [119].

Current treatment strategies are mainly based on sleep hygiene techniques and cognitive behavioural techniques; and via the use of hypnotic or antidepressant medications [120]. Additionally, the use of lifestyle modification programs may improve sleep by addressing factors associated poor sleep e.g. sedentary life, poor diet, caffeine and alcohol use. Merrill and colleagues [121] analyzed data from a lifestyle change program involving 2,624 individuals aged 30 to 80 years from the Illinois USA area. Participants were assessed at baseline and then again after four weeks of completing a 40 hour program which educated them on making long-term improvements in nutrition and physical activity and sleep habits. While the study was uncontrolled and the assessments were potentially open to bias (thus caution in interpreting this study is advised), results revealed that of the 10% of participants who were experiencing insomnia, 64% no longer had a sleep disturbance at the conclusion of the study. Increased PA and a lowering of BMI and caffeine consumption was associated with improved sleep. Changes in alcohol consumption and smoking however were not found to significantly contribute to improvement in sleep.

Social interaction

Another key lifestyle influence affecting mental health concerns a person’s social environment. Positive, supportive, intimate relationships, be it via family, friends or a relationship, have been established to have a beneficial effect on general health, and in particular for maintaining psychological health [122]. Ibarra-Rovillard and Kuiper [122] propose that the extent to which social relationship partners are perceived to fulfill (or undermine) basic psychological needs serves to explain both the positive and negative effects on the well-being of depressed individuals. Data from the English Longitudinal Study of Aging, observed whether baseline positive and negative exchanges with partners, family and friends were linked to two-year changes in depression [123]. Results showed that after adjusting for confounding factors, negative, but not positive, exchanges with family and friends were associated with greater occurrence of depression. A positive relationship has also been shown between social support and leisure time physical activity (LTPA) [124]. A prospective cohort study of 5395 middle-aged adults participating in the British Whitehall II study found that amongst participants who reported recommended levels of LTPA at baseline, adults who experienced high emotional support were more likely to report recommended levels of LTPA at follow-up. These findings suggest that the enhancement of social networks and increased social support may help the individual to maintain the recommended level of LTPA. While adequate LTPA may potentially provide a psychologically beneficial effect, data is needed assessing its relation to depression.

Lifestyle elements with emerging data

Recreation and relaxation

A vital lifestyle element in the management of depression is the pursuit of balancing the “work-rest-play” dynamic. While the specific effect of pleasurable recreational activities as a treatment for clinical depression per se has not been adequately evaluated, it is plausible that this is a meaningful consideration. Recreational activities provide an opportunity to experience pleasure, to direct the mind away from rumination and worry, and may provide a setting for increased social interaction. The benefits of participation in organised physical recreation have been investigated as one strategy for enhancing mental health and wellbeing. As Street, James and Cutt comment [125], evaluations by government departments in Australia and the US have found that people who participate in organised recreational activity enjoy better mental health, are more resilient against the stresses of modern living, with a reduction of depressed mood also evident; however the direction of the association remains speculative. One common form of inexpensive recreation involves listening to music. Studies of varying methodological quality have been conducted assessing this for reducing depressive symptoms [126]. A systematic review of 17 studies found that listening to music over a period of time helps to reduce depressive symptoms in adults. No specific type of music was found to be superior, with personal preference recommended.

Aside from recreational activities that may provide psychological relaxation, formalized relaxation techniques may also be incorporated into people’s lifestyle. A Cochrane Review and meta-analysis by Jorm and colleagues [127] of 11 trials using relaxation techniques (progressive muscle relaxation, relaxation imagery, autogenic training) versus control (wait-list, no or minimal treatment), found that although clinician-rated outcomes were non-significant, self-rated depressive symptoms were reduced, with a moderate effect size reported. Specifically, a meta-analysis of five trials found that relaxation reduced self-reported depression compared to wait-list, no treatment, or minimal treatment post intervention (although these are not optimal control conditions). It should also be noted a meta-analysis of nine trials revealed that relaxation produced less effect than psychological interventions on self-reported depression.

Environmental factors

A range of transpersonal elements are modifiable factors that may have effects on mental health and depression. External factors that may affect health can be categorized into environmental: nature/greenspace; climate, season, pollution (noise, air and water quality, chemical exposure) and social: interaction with family, friends and relationships, and a therapeutic association with animals or pets. It should be noted that while there is evidence of social interaction and support being potentially protective in depression (discussed above), there is currently only weak evidence regarding the other elements.

Adequate exposure to nature (greenspace) may provide theoretical benefits for general health. Although being close to greenspace may not necessarily be correlated with increased PA, studies have shown a relationship to a range of positive health effects [128]. The benefits of spending time in nature may also involve increased exposure to fresh air and sunlight. While the evidence of specific health benefits from “nature-assisted” therapy (for example nature hikes) is unclear due to a deficit of rigorous studies, the extant evidence suggests a therapeutic effect. A systematic review by Annerstedt and Wahrborg [129] found that for studies of moderate to low evidence grade, health improvements were reported in 26 out of 29 studies. Exercising in nature also may synergistically increase wellbeing beyond PA in an urban setting [130].

It is a commonly held belief that people feel better “when the sun is shining”, however whilst acute exposure to sunlight and a pleasant temperature may anecdotally enhance mood, there appears to be an inconsistent relationship between seasonal variations and the prevalence of depression [131, 132]. The beneficial effect of sunlight exposure on mental health has been suggested to be mediated, in part, by vitamin D [133]. However recent research involving 198 people with multiple sclerosis who were followed prospectively for an average of 2.3 years, showed that greater exposure to sunshine may decrease depressive symptoms, despite no correlation to vitamin D levels [134]. Low levels of vitamin D appear to be associated with depression risk, although there is conflicting evidence as to the effects of supplementation on improving mood [33, 133, 135]. Currently, the breadth of evidence provides inconsistent support for the use of vitamin D supplementation for depression.

Other environmental factors that are under current investigation pertain to noise pollution, and exposure to technological devices. While no direct link to depression has been documented, continual hyperstimulation is a theoretical concern for both cognition and mental health. Environmental toxins (including particulate air pollution) are also an issue, having a potential effect on the central nervous system [136]. Emerging evidence suggests that air pollution may induce neuroinflammation, oxidative stress, microglial activation, cerebrovascular dysfunction, while potentially altering the blood–brain barrier [136]. A recent novel mouse model study investigated whether long-term (10 months) exposure to ambient fine airborne particulate matter compared to filtered air, affects affective and cognitive responses [137]. Results revealed that mice exposed to long-term air pollution displayed more depressive-like responses and impairments in spatial learning and memory compared with mice exposed to filtered air. Exposure to air pollution has been found to be associated with an increase in depressive symptoms in a longitudinal study of 537 elderly Koreans [11]. However, the evidence currently does not clearly confirm the relationship between pollution and depression, with NHANES data (unpublished) failing to demonstrate a consistent relationship between persistent organic and heavy metal pollutants and depression.

Animal and pet therapy

Humans commonly have close relationships with animals, particularly pets, and such relationships may have a theoretical benefit for alleviating depressed mood. Having a pet can provide physical affection and a feeling of unconditional love, assist in the maintenance of a routine, and also provide responsibility and an additional sense of life purpose. Formalized animal-assisted therapy may involve horses (equine therapy), dogs, or even interactions with mammals such as dolphins. Time spent with farm animals by people with psychiatric disorders may reduce depression and state anxiety, and increase a sense of self-efficacy [138], with a small and methodologically limited study suggesting beneficial effects of pet therapy on mood and perceived quality of life in 21 elderly inpatients affected by dementia, depression and psychosis [139]. No clinical recommendations are possible given the available data.

Clinical considerations

The application of Lifestyle Medicine should be considered in the context of long-term sustainability. Motivational issues, time restrictions, financial limitations, the perspective about the source of their difficulties and treatment priorities, may influence a patient’s ability to implement lifestyle changes. Adherence and engagement are increased by having ownership of a treatment plan and a sense of shared partnership in its development and planning. Treatment strategies should therefore be developed taking cognisance of the above factors, and the treatment package should be individually tailored and offered in a step-wise manner. It is also necessary to consider readiness to change when engaging in discussion regarding lifestyle modification, and concordant with the transtheoretical model, to only embark on this when the person has moved beyond precontemplation to the contemplation or preparation stages [140]. Some lifestyle choices and “vices” may provide the person self-perceived support and comfort, and in such cases change needs to be handled delicately. Often, strict advice promoting abstinence, or a demanding diet or exercise regime, may cause added suffering, and may also provoke guilt if the person cannot meet these expectations, or lead to paradoxical behaviour if oppositional cognitive schema are activated.

With respect to specific dietary advice, it is important to recognise that the nutrients critical for neurological function (magnesium, folate, zinc and essential fatty acids), and are all components of a healthy diet, found primarily in foods such as leafy green vegetables, legumes, wholegrains, lean red meat and fish. Foods rich in polyphenols (e. g. berries, tea, dark chocolate, wine and certain herbs), are also valuable for cognitive and cardiovascular function [141, 142]. Aside from having adequate wholefoods, people are also advised to reduce processed foods, refined carbohydrates and sugars, and transaturated fats. Adherence to the Mediterranean diet has also been shown to be associated with a range of mental health benefits.

Regarding the dosage and type of exercise to recommend, research indicates that a dose-dependent effect occurs, with regular moderate to strong intensity exercise eliciting more positive results [143, 144]. Clinical guidelines for exercise recommend physician assessment (or referral to an exercise physiologist) before commencing a new regime, which should consist of moderate to vigorous aerobic exercise (30–60 minutes) in addition to anaerobic weight-bearing exercises approximately four to six days per week [145, 146]. Exposure to social interaction and nature when exercising may be useful on theoretical grounds.

The integration of meditative practices can be readily incorporated into most people’s lifestyle. While regular formal practice of meditation or yoga can be recommended, it can be applied in simple forms, such as mindful walking or eating, or yoga breathing exercises. With respect to yoga, it is advised that people pursue instruction under a qualified instructor, and proceed in a graded manner; as is the case for all forms of exercise. Patients with glaucoma (with any inverted poses), osteoporosis (with any heavy weight-bearing pose), should proceed with caution.

Due to the potential impact of heavy alcohol use on the risk and treatment for depression [147, 148], routine clinical questioning about alcohol consumption is appropriate. In a clinical setting, the focus should be on differentiating and managing problem drinking (where it is identified), and on psycho-education of patients regarding modest alcohol consumption and avoiding heavy episodic drinking. Further education may be required regarding potential interactions between alcohol use and medications. Techniques combining motivational interviewing and cognitive behavioural therapy may be of benefit in treating the dual components of depression and problem drinking [149, 150].

Smoking cessation should also form a routine component of clinical care, with individuals being offered evidence-based smoking cessation interventions when appropriate [151]. Interestingly, PA used concurrently with smoking cessation seems to be protective against relapse in quitters, further reinforcing recommendations regarding exercise [152]. One caveat is required: the act of cessation is associated with withdrawal symptoms including transient dysphoria, irritability and a risk of aggravation of depression [153]. However, once the neurochemical set-point has re-adapted to the absence of nicotine, this should normalize. While trials of smoking cessation that examine long term change in depression risk have not been conducted, recent data suggests that quitting smoking is associated with better social functioning and self-perceived health status [154].

Sleep hygiene techniques that can be offered in the case of poor sleep or insomnia, includes focusing on adjusting caffeine use, limiting exposure to the bed (sleep restriction) with the patient having only a limited time to sleep, and getting up at a set time in the morning [155]. This should regulate the circadian rhythm, which is of particular significance in people with affective disorders [115]. Reducing exposure to light prior to sleep to increase melatonin secretion is of theoretical value [156], as is increased exposure to morning sunlight upon waking. Further sleep hygiene advice includes stimulus control: avoidance of stimulating activity and stimulants close to sleep (for example, smoking, caffeine and stimulating TV or books), and quiescent sleep preparation. Although evening meal portions should not be excessive (this may cause rebound hypoglycaemia), sufficient calorific intake is required to avoid waking up due to hunger.

Other lifestyle targets can consist of emphasising the importance of social contact, and the theoretically positive benefits of animals/pets [122, 139]. The therapeutic benefits of spending time in nature is supported by a limited dataset [129]. Adequate exposure to sunlight should enhance vitamin D levels and serotonin turnover [157], however this needs to be balanced with concerns over skin cancer, thus time of day/year and skin colour are factors in consideration about the amount of sun exposure recommended. While current data are weak with respect to an association with depression, limited exposure to environmental toxins, chemicals pollutants [136] and noise pollution [158], is also a valid general health consideration. While limited study in this area has been pursued and there is no direct link to depression, moderation of excessive technological interface (e.g. mobile phones, computers, television) is also a potential consideration in Lifestyle Medicine [2].

Summary

While many factors, including genetics, personality and cognition, and environmental stressors contribute to the aetiology of depression, lifestyle components may have an important role in the disorder’s pathogenesis. Currently, the contemporary clinical management of depression has had more of a focus on medication and psychotherapy, and to date, has not widely incorporated the evidence regarding many lifestyle factors into guidelines. As outlined above, there is evolving evidence to support the modification of selected lifestyle elements. Further research is now needed to study “integrative models” assessing the application of prescriptive Lifestyle Medicine, similar to those used in other medical populations [159]. Trial designs could explore individualized tailored programs, or the step-wise application of individual components according to patient interest or need. While the study would not be double-blinded, it is possible to randomize participants into the active lifestyle modification group versus a placebo or inactive group, with the outcomes being assessed by an independent blinded researcher (using validated psychiatric scales). Further work exploring the mechanistic underpinnings of lifestyle modification is also of benefit.

In future respect to the research underpinning lifestyle modification for depression, aside from prospective RCTs needing to assess some lesser studied lifestyle elements such as dietary modification, one critical area of study is to explore the effects of an integrated multi-faceted application of lifestyle medicine. To date, to our knowledge only one RCT has examined the effects of combining multiple lifestyle adjustments for the treatment of depression. Garcia-Toro and colleagues [160] conducted an RCT of 80 outpatients with diagnosed major depressive disorder (non-SAD) who were taking antidepressant treatment. Four specific lifestyle recommendations consisting of dietary modification, exercise, sunlight exposure and sleep patterns were prescribed in the active group, while the control group was given instruction to perform a pattern of eating, sleeping, exercise and exposure to light which they considered might make them feel better. Blinded assessment was conducted before and after the six month intervention period. The active group had a significantly greater reduction of depression than the control group, with 11 out of 40 people (28%) in the active group achieving remission (HAM-D < 7), compared to only one person in the control group. These encouraging results are in line with remission rates of standard antidepressants, and support the conduct of similar more definitive studies.

Conclusions

In conclusion, a variety of lifestyle modifications exist that have appropriate potential front-line clinical application alongside pharmacotherapies and psychological techniques to better manage depression. While the judicious use of medication and psychological techniques are still advocated, due to the complexity of human illness/wellbeing, the time has come for a more integrative approach for depression, and an acknowledgment of the potential applicability of lifestyle modification.

References

  1. 1.

    Hidaka BH: Depression as a disease of modernity: explanations for increasing prevalence. J Affect Disord. 2012, 140 (3): 205-214. 10.1016/j.jad.2011.12.036.

  2. 2.

    Walsh R: Lifestyle and mental health. Am Psychol. 2011, 66 (7): 579-592.

  3. 3.

    Egger GJ, Binns AF, Rossner SR: The emergence of “lifestyle medicine” as a structured approach for management of chronic disease. Med J Aust. 2009, 190 (3): 143-145.

  4. 4.

    WHO: Mental and Neurological disorders ‘Depression’. 2012, http://www.who.int/whr/2001/media_centre/en/whr01_fact_sheet1_en.pdf,

  5. 5.

    Jacka F, Mykletun A, Berk M: Moving towards a population health approach to the primary prevention of common mental disorders. BMC Med. 2012, 10 (1): 149-10.1186/1741-7015-10-149.

  6. 6.

    Morgan AJ, Jorm AF: Self-help strategies that are helpful for sub-threshold depression: a Delphi consensus study. J Affect Disord. 2009, 115 (1–2): 196-200.

  7. 7.

    Parker G, Crawford J: Judged effectiveness of differing antidepressant strategies by those with clinical depression. Aust N Z J Psychiatry. 2007, 41 (1): 32-37. 10.1080/00048670601057726.

  8. 8.

    Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, Zitman FG: Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010, 67 (3): 220-229. 10.1001/archgenpsychiatry.2010.2.

  9. 9.

    Jacka FN, Pasco JA, Mykletun A, Williams LJ, Hodge AM, O’Reilly SL, Nicholson GC, Kotowicz MA, Berk M: Association of Western and traditional diets with depression and anxiety in women. Am J Psychiatry. 2010, 167 (3): 305-311. 10.1176/appi.ajp.2009.09060881.

  10. 10.

    Roth T: Insomnia as a risk factor for depression. Int J Neuropsychopharmacol. 2004, 7: S34-S35.

  11. 11.

    Lim YH, Kim H, Kim JH, Bae S, Park HY, Hong YC: Air pollution and symptoms of depression in elderly adults. Environ Health Perspect. 2012, 120 (7): 1023-1028. 10.1289/ehp.1104100.

  12. 12.

    van Praag HM: Can stress cause depression?. Prog Neuropsychopharmacol Biol Psychiatry. 2004, 28 (5): 891-907. 10.1016/j.pnpbp.2004.05.031.

  13. 13.

    Raison CL, Capuron L, Miller AH: Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27 (1): 24-31. 10.1016/j.it.2005.11.006.

  14. 14.

    Maes M, Fisar Z, Medina M, Scapagnini G, Nowak G, Berk M: New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates-Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology. 2012, 20 (3): 127-150. 10.1007/s10787-011-0111-7.

  15. 15.

    Nielsen SJ, Siega-Riz AM, Popkin BM: Trends in energy intake in U.S. between 1977 and 1996: similar shifts seen across age groups. Obes Res. 2002, 10 (5): 370-378. 10.1038/oby.2002.51.

  16. 16.

    Kant AK: Consumption of energy-dense, nutrient-poor foods by adult Americans: nutritional and health implications. The third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr. 2000, 72 (4): 929-936.

  17. 17.

    Jacka FN, Pasco JA, Mykletun A, Williams LJ, Nicholson GC, Kotowicz MA, Berk M: Diet quality in bipolar disorder in a population-based sample of women. J Affect Disord. 2011, 129 (1–3): 332-337.

  18. 18.

    Nanri A, Kimura Y, Matsushita Y, Ohta M, Sato M, Mishima N, Sasaki S, Mizoue T: Dietary patterns and depressive symptoms among Japanese men and women. Eur J Clin Nutr. 2010, 64 (8): 832-839. 10.1038/ejcn.2010.86.

  19. 19.

    Samieri C, Jutand MA, Feart C, Capuron L, Letenneur L, Barberger-Gateau P: Dietary patterns derived by hybrid clustering method in older people: association with cognition, mood, and self-rated health. J Am Diet Assoc. 2008, 108 (9): 1461-1471. 10.1016/j.jada.2008.06.437.

  20. 20.

    Aihara Y, Minai J, Aoyama A, Shimanouchi S: Depressive symptoms and past lifestyle among Japanese elderly people. Community Ment Health J. 2011, 47 (2): 186-193. 10.1007/s10597-010-9317-1.

  21. 21.

    Mamplekou E, Bountziouka V, Psaltopoulou T, Zeimbekis A, Tsakoundakis N, Papaerakleous N, Gotsis E, Metallinos G, Pounis G, Polychronopoulos E, Gotsis E, Metallinos G, Pounis G, Polychronopoulos E, Lionis C, Panagiotakos D: Urban environment, physical inactivity and unhealthy dietary habits correlate to depression among elderly living in eastern Mediterranean islands: the MEDIS (MEDiterranean ISlands Elderly) study. J Nutr Health Aging. 2010, 14 (6): 449-455. 10.1007/s12603-010-0091-0.

  22. 22.

    Jacka FN, Kremer PJ, Leslie E, Berk M, Patton G, Toumbourou JW, Williams JW: Associations between diet quality and depressed mood in adolescents: results from the healthy neighbourhoods study. Aust N Z J Psychiatry. 2010, 44 (5): 435-442. 10.3109/00048670903571598.

  23. 23.

    Overby N, Hoigaard R: Diet and behavioral problems at school in Norwegian adolescents. Adv Food Nutr Res. 2012, 56: Epub 2012 Jun 28

  24. 24.

    Weng TT, Hao JH, Qian QW, Cao H, Fu JL, Sun Y, Huang L, Tao FB: Is there any relationship between dietary patterns and depression and anxiety in Chinese adolescents?. Public Health Nutr. 2012, 15 (4): 673-82.

  25. 25.

    Oddy WH, Robinson M, Ambrosini GL, O’Sullivan TA, de Klerk NH, Beilin LJ, Silburn SR, Zubrick SR, Stanley FJ: The association between dietary patterns and mental health in early adolescence. Prev Med. 2009, 49: 39-44. 10.1016/j.ypmed.2009.05.009.

  26. 26.

    Akbaraly TN, Brunner EJ, Ferrie JE, Marmot MG, Kivimaki M, Singh-Manoux A: Dietary pattern and depressive symptoms in middle age. Br J Psychiatry. 2009, 195 (5): 408-413. 10.1192/bjp.bp.108.058925.

  27. 27.

    Jacka F, Kremer PJ, Berk M, de Silva-Sanigorski A, Moodie M, Leslie E, Pasco J, Swinburn B: A prospective study of diet quality and mental health in adolescents. PLoS One. 2011, 6 (9): e24805-10.1371/journal.pone.0024805.

  28. 28.

    Sanchez-Villegas A, Delgado-Rodriguez M, Alonso A, Schlatter J, Lahortiga F, Majem LS, Martinez-Gonzalez MA: Association of the Mediterranean dietary pattern with the incidence of depression: the Seguimiento Universidad de Navarra/University of Navarra follow-up (SUN) cohort. Arch Gen Psychiatry. 2009, 66 (10): 1090-1098. 10.1001/archgenpsychiatry.2009.129.

  29. 29.

    Park JY, You JS, Chang KJ: Dietary taurine intake, nutrients intake, dietary habits and life stress by depression in Korean female college students: a case–control study. J Biomed Sci. 2010, 17 (Suppl 1): S40-10.1186/1423-0127-17-S1-S40.

  30. 30.

    Chatzi L, Melaki V, Sarri K, Apostolaki I, Roumeliotaki T, Georgiou V, Vassilaki M, Koutis A, Bitsios P, Kogevinas M: Dietary patterns during pregnancy and the risk of postpartum depression: the mother-child ‘Rhea’ cohort in Crete, Greece. Public Health Nutr. 2011, 14 (9): 1663-1670.

  31. 31.

    Quirk SE, Williams LJ, O’Neil A, Pasco JA, Jacka FN, Housden S, Berk M, Brennan SL: The association between diet quality, dietary patterns and depression in adults: a systematic review. BMC Psychiatry. 2013, 13: 175-10.1186/1471-244X-13-175.

  32. 32.

    Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yucel M, Gama CS, Dodd S, Dean B, Magalhães PV, Amminger P, McGorry P, Malhi GS: Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2010, 35 (3): 804-817.

  33. 33.

    Berk M, Jacka F: Preventive strategies in depression: gathering evidence for risk factors and potential interventions. Br J Psychiatry. 2012, 201: 339-341. 10.1192/bjp.bp.111.107797.

  34. 34.

    Nettleton J, Matijevic N, Follis J, Folsom A, Boerwinkle E: Associations between dietary patterns and flow cytometry-measured biomarkers of inflammation and cellular activation in the Atherosclerosis Risk in Communities (ARIC) Carotid Artery MRI study. Atherosclerosis. 2010, 212 (1): 260-267. 10.1016/j.atherosclerosis.2010.04.026.

  35. 35.

    Pasco JA, Nicholson GC, Williams LJ, Jacka FN, Henry MJ, Kotowicz MA, Schneider HG, Leonard BE, Berk M: Association of high-sensitivity C-reactive protein with de novo major depression. Br J Psychiatry. 2010, 197 (5): 372-377. 10.1192/bjp.bp.109.076430.

  36. 36.

    Maes M, Ruckoanich P, Chang YS, Mahanonda N, Berk M: Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35 (3): 769-783. 10.1016/j.pnpbp.2010.06.008.

  37. 37.

    Maes M, Galecki P, Chang YS, Berk M: A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry. 2010, 35 (3): 676-692.

  38. 38.

    Berk M, Wadee AA, Kuschke RH, O’Neill-Kerr A: Acute phase proteins in major depression. J Psychosom Res. 1997, 43 (5): 529-534. 10.1016/S0022-3999(97)00139-6.

  39. 39.

    Rucklidge JJ, Kaplan BJ: Broad-spectrum micronutrient formulas for the treatment of psychiatric symptoms: a systematic review. Expert Rev Neurother. 2013, 13 (1): 49-73. 10.1586/ern.12.143.

  40. 40.

    Jacka FN, Maes M, Pasco JA, Williams LJ, Berk M: Nutrient intakes and the common mental disorders in women. J Affect Disord. 2012, 141 (1): 79-85. 10.1016/j.jad.2012.02.018.

  41. 41.

    Sarris J, Schoendorfer N, Kavanagh DJ: Major depressive disorder and nutritional medicine: a review of monotherapies and adjuvant treatments. Nutr Rev. 2009, 67 (3): 125-131. 10.1111/j.1753-4887.2009.00180.x.

  42. 42.

    Jacka FN, Berk M: Food for thought. Acta Neuropsychiatr. 2007, 19 (5): 321-323. 10.1111/j.1601-5215.2007.00246.x.

  43. 43.

    McMillan L, Owen L, Kras M, Scholey A: Behavioural effects of a 10-day Mediterranean diet. Results from a pilot study evaluating mood and cognitive performance. Appetite. 2010, 56 (1): 143-147.

  44. 44.

    Appleton KM, Rogers PJ, Ness AR: Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr. 2010, 91 (3): 757-770. 10.3945/ajcn.2009.28313.

  45. 45.

    Sublette M, Ellis S, Geant A, Mann J: Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry. 2011, 72 (12): 1577-1584. 10.4088/JCP.10m06634.

  46. 46.

    Sarris J, Mischoulon D, Schweitzer I: Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials. Bipolar Disord. 2011, 13 (5–6): 454-465.

  47. 47.

    O’Neil A, Berk M, Itsiopoulos C, Castle D, Opie R, Pizzinga J, Brazionis L, Hodge A, Mihalopoulos C, Chatterton ML, Dean OM, Jacka FN: A randomised, controlled trial of a dietary intervention for adults with major depression (the “SMILES” trial): study protocol. BMC Psychiatry. 2013, 13: 114-10.1186/1471-244X-13-114.

  48. 48.

    McIntyre RS, Alsuwaidan M, Goldstein BI, Taylor VH, Schaffer A, Beaulieu S, Kemp DE: The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders. Ann Clin Psychiatry. 2012, 24 (1): 69-81.

  49. 49.

    (WHO) WHO: Diet, nutrition, and the prevention of chronic diseases. Report of a WHO study group. WHO Technical Report Series No 916. 2003, Geneva: World Health Organisation (WHO)

  50. 50.

    Yarborough BJ, Janoff SL, Stevens VJ, Kohler D, Green CA: Delivering a lifestyle and weight loss intervention to individuals in real-world mental health settings: lessons and opportunities. Transl Behav Med. 2011, 1 (3): 406-415. 10.1007/s13142-011-0056-9.

  51. 51.

    Lucas M, Mekary R, Pan A, Mirzaei F, O’Reilly EJ, Willett WC, Koenen K, Okereke OI, Ascherio A: Relation between clinical depression risk and physical activity and time spent watching television in older women: a 10-year prospective follow-up study. Am J Epidemiol. 2011, 174 (9): 1017-1027. 10.1093/aje/kwr218.

  52. 52.

    Galper DI, Trivedi MH, Barlow CE, Dunn AL, Kampert JB: Inverse association between physical inactivity and mental health in men and women. Med Sci Sports Exerc. 2006, 38 (1): 173-178. 10.1249/01.mss.0000180883.32116.28.

  53. 53.

    Farmer M, Locke B, Moscicki E, Dannenberg A, Larson D, Radloff L: Physical activity and depressive symptoms: the NHANES I Epidemiologic follow-up study. Am J Epidemiol. 1988, 128 (6): 1340-1351.

  54. 54.

    Brown WJ, Ford JH, Burton NW, Marshall AL, Dobson AJ: Prospective study of physical activity and depressive symptoms in middle-aged women. Am J Prev Med. 2005, 29 (4): 265-272. 10.1016/j.amepre.2005.06.009.

  55. 55.

    Jacka FN, Pasco JA, Williams LJ, Leslie ER, Dodd S, Nicholson GC, Kotowicz MA, Berk M: Lower levels of physical activity in childhood associated with adult depression. J Sci Med Sport. 2011, 14 (3): 222-226. 10.1016/j.jsams.2010.10.458.

  56. 56.

    Pasco JA, Williams LJ, Jacka FN, Henry MJ, Coulson CE, Brennan SL, Leslie E, Nicholson GC, Kotowicz MA, Berk M: Habitual physical activity and the risk for depressive and anxiety disorders among older men and women. Int Psychogeriatr. 2011, 23 (2): 292-298. 10.1017/S1041610210001833.

  57. 57.

    De Moor MH, Boomsma DI, Stubbe JH, Willemsen G, de Geus EJ: Testing causality in the association between regular exercise and symptoms of anxiety and depression. Arch Gen Psychiatry. 2008, 65 (8): 897-905. 10.1001/archpsyc.65.8.897.

  58. 58.

    Ng F, Dodd S, Berk M: The effects of physical activity in the acute treatment of bipolar disorder: a pilot study. J Affect Disord. 2007, 101 (1–3): 259-262.

  59. 59.

    Ng F, Dodd S, Jacka FN, Leslie E, Berk M: Effects of a walking program in the psychiatric in-patient treatment setting: a cohort study. Health Promot J Austr. 2007, 18 (1): 39-42.

  60. 60.

    Chaouloff F: Effects of acute physical exercise on central serotonergic systems. Med Sci Sports Exerc. 1997, 29 (1): 58-62. 10.1097/00005768-199701000-00009.

  61. 61.

    Sarris J, Kavanagh D, Newton R: Depression and exercise. J Complement Med. 2008, 3: 48-50,61.

  62. 62.

    Deslandes A, Moraes H, Ferreira C, Veiga H, Silveira H, Mouta R, Pompeu FA, Coutinho ES, Laks J: Exercise and mental health: many reasons to move. Neuropsychobiology. 2009, 59 (4): 191-198. 10.1159/000223730.

  63. 63.

    Berk M, Conus P, Kapczinski F, Andreazza AC, Yucel M, Wood SJ, Pantelis C, Malhi GS, Dodd S, Bechdolf A, Amminger GP, Hickie IB, McGorry PD: From neuroprogression to neuroprotection: implications for clinical care. Med J Aust. 2010, 193 (4 Suppl): S36-S40.

  64. 64.

    Duman R: Neurotrophic factors and regulation of mood: Role of exercise, diet and metabolism. Neurobiol Aging. 2005, 26S: S88-S93.

  65. 65.

    Erickson KI, Miller DL, Roecklein KA: The aging hippocampus: interactions between exercise, depression, and BDNF. Neuroscientist. 2012, 18 (1): 82-97. 10.1177/1073858410397054.

  66. 66.

    Ernst C, Olson AK, Pinel JPJ, Lam RW, Christie BR: Antidepressant effects of exercise: evidence for an adult-neurogenesis hypothesis?. J Psychiatry Neurosci. 2006, 31 (2): 84-92.

  67. 67.

    Dey S, Singh RH, Dey PK: Exercise training: significance of regional alterations in serotonin metabolism of rat brain in relation to antidepressant effect of exercise. Physiol Behav. 1992, 52 (6): 1095-1099. 10.1016/0031-9384(92)90465-E.

  68. 68.

    Mastorakos G, Pavlatou M, Diamanti-Kandarakis E, Chrousos GP: Exercise and the stress system. Hormones (Athens). 2005, 4 (2): 73-89.

  69. 69.

    T B, G N, I B, Tefner I, Kádas E, Géher P: The effect of physical therapy on beta-endorphin levels. Eur J Appl Physiol. 2007, 100 (4): 371-382. 10.1007/s00421-007-0469-9. Epub 2007 May 5

  70. 70.

    Moylan S, Eyre H, Maes M, Baune B, Jacka F, Berk M: Exercising the worry away: How inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours. Neurosci Biobehav Rev. 2013, [Epub ahead of print]

  71. 71.

    Rimer J, Dwan K, Lawlor DA, Greig CA, McMurdo M, Morley W, Mead GE: Exercise for depression. Cochrane Database Syst Rev. 2012, 7: CD004366

  72. 72.

    Cramer H, Lauche R, Langhorst J, Dobos G: Yoga for depression: a systematic review and meta-analysis. Depress Anxiety. 2013, 30 (11): 1068-1083. 10.1002/da.22166.

  73. 73.

    Cramer H, Krucoff C, Dobos G: Adverse events associated with yoga: a systematic review of published case reports and case series. PLoS One. 2013, 8 (10): e75515-10.1371/journal.pone.0075515.

  74. 74.

    Kabat-Zinn J: Wherever You Go, There You Are: Mindfulness Meditation in Everyday Life. 1994, Hyperion: Body, Mind & Spirit, 304-

  75. 75.

    Kabat-Zinn J, Massion AO, Kristeller J, Peterson LG, Fletcher KE, Pbert L, Lenderking WR, Santorelli SF: Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. Am J Psychiatry. 1992, 149 (7): 936-943.

  76. 76.

    Lazar SW, Kerr CE, Wasserman RH, Gray JR, Greve DN, Treadway MT, McGarvey M, Quinn BT, Dusek JA, Benson H, Rauch SL, Moore CI, Fischl B: Meditation experience is associated with increased cortical thickness. Neuroreport. 2005, 16 (17): 1893-1897. 10.1097/01.wnr.0000186598.66243.19.

  77. 77.

    Yu X, Fumoto M, Nakatani Y, Sekiyama T, Kikuchi H, Seki Y, Sato-Suzuki I, Arita H: Activation of the anterior prefrontal cortex and serotonergic system is associated with improvements in mood and EEG changes induced by Zen meditation practice in novices. Int J Psychophysiol. 2011, 80 (2): 103-111. 10.1016/j.ijpsycho.2011.02.004.

  78. 78.

    Chiesa A, Serretti A: A systematic review of neurobiological and clinical features of mindfulness meditations. Psychol Med. 2010, 40 (8): 1239-1252. 10.1017/S0033291709991747.

  79. 79.

    Hofmann SG, Sawyer AT, Witt AA, Oh D: The effect of mindfulness-based therapy on anxiety and depression: a meta-analytic review. J Consult Clin Psychol. 2010, 78 (2): 169-183.

  80. 80.

    Swendsen JD, Merikangas KR, Canino GJ, Kessler RC, Rubio-Stipec M, Angst J: The comorbidity of alcoholism with anxiety and depressive disorders in four geographic communities. Compr Psychiatry. 1998, 39 (4): 176-184. 10.1016/S0010-440X(98)90058-X.

  81. 81.

    Clapp P, Bhave SV, Hoffman PL: How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective. Alcohol Res Health. 2008, 31 (4): 310-339.

  82. 82.

    Boden JM, Fergusson DM: Alcohol and depression. Addiction. 2012, 106 (5): 906-914.

  83. 83.

    Brook DW, Brook JS, Zhang C, Cohen P, Whiteman M: Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Arch Gen Psychiatry. 2002, 59: 1039-1044. 10.1001/archpsyc.59.11.1039.

  84. 84.

    Caldwell TM, Rogers B, Jorm AF, Christensen H, Jacomb PA, Korten AE, Lynskey M: Patterns of association between alcohol consumption and syndromes of depression and anxiety in young adults. Addiction. 2002, 97: 583-594. 10.1046/j.1360-0443.2002.00092.x.

  85. 85.

    Liappas J, Paparrigopoulos T, Tzavellas E, Christodoulou G: Impact of alcohol detoxification on anxiety and depressive symptoms. Drug Alcohol Depend. 2002, 68 (2): 215-220. 10.1016/S0376-8716(02)00195-3.

  86. 86.

    Schuckit MA: Alcohol and depression: a clinical perspective. Acta Psychiatr Scand. 1994, 377: 28-32.

  87. 87.

    Davidson KM: Diagnosis of depression in alcohol dependence: changes in prevalence with drinking status. Br J Psychiatry. 1995, 166 (2): 199-204. 10.1192/bjp.166.2.199.

  88. 88.

    Wilton G, Moberg DP, Fleming MF: The effect of brief alcohol intervention on postpartum depression. MCN Am J Matern Child Nurs. 2009, 34 (5): 297-302. 10.1097/01.NMC.0000360422.06486.c4.

  89. 89.

    Klungsoyr O, Nygard JF, Sorensen T, Sandanger I: Cigarette smoking and incidence of first depressive episode: an 11-year, population-based follow-up study. Am J Epidemiol. 2006, 163 (5): 421-432. 10.1093/aje/kwj058.

  90. 90.

    Choi WS, Patten CA, Gillin JC, Kaplan RM, Pierce JP: Cigarette smoking predicts development of depressive symptoms among U.S. adolescents. Ann Behav Med. 1997, 19 (1): 42-50. 10.1007/BF02883426.

  91. 91.

    Johnson EO, Breslau N: Is the association of smoking and depression a recent phenomenon?. Nicotine Tob Res. 2006, 8 (2): 257-262. 10.1080/14622200600576644.

  92. 92.

    Wu LT, Anthony JC: Tobacco smoking and depressed mood in late childhood and early adolescence. Am J Public Health. 1999, 89 (12): 1837-1840. 10.2105/AJPH.89.12.1837.

  93. 93.

    Moylan S, Jacka F, Pasco J, Berk M: Cigarette smoking, nicotine dependence and anxiety disorders: a systematic review of population-based, epidemiological studies. BMC Med. 2012, 10: 123-10.1186/1741-7015-10-123.

  94. 94.

    Pasco JA, Williams LJ, Jacka FN, Ng F, Henry MJ, Nicholson GC, Kotowicz MA, Berk M: Tobacco smoking as a risk factor for major depressive disorder: population-based study. Br J Psychiatry. 2008, 193 (4): 322-326. 10.1192/bjp.bp.107.046706.

  95. 95.

    Steuber TL, Danner F: Adolescent smoking and depression: which comes first?. Addict Behav. 2006, 31 (1): 133-136. 10.1016/j.addbeh.2005.04.010.

  96. 96.

    Kendler KS, Neale MC, MacLean CJ, Heath AC, Eaves LJ, Kessler RC: Smoking and major depression. A causal analysis. Arch Gen Psychiatry. 1993, 50 (1): 36-43. 10.1001/archpsyc.1993.01820130038007.

  97. 97.

    Jamal M, Willem Van der Does AJ, Cuijpers P, Penninx BW: Association of smoking and nicotine dependence with severity and course of symptoms in patients with depressive or anxiety disorder. Drug Alcohol Depend. 2012, 126 (1-2): 138-146. 10.1016/j.drugalcdep.2012.05.001.

  98. 98.

    Berk M, Ng F, Wang WV, Tohen M, Lubman DI, Vieta E, Dodd S: Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania. J Affect Disord. 2008, 110 (1–2): 126-134.

  99. 99.

    Dodd S, Brnabic AJ, Berk L, Fitzgerald PB, de Castella AR, Filia S, Filia K, Kelin K, Smith M, Montgomery W, Kulkarni J, Berk M: A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder. Compr Psychiatry. 2010, 51 (5): 504-509. 10.1016/j.comppsych.2009.12.001.

  100. 100.

    Weinberger AH, Pilver CE, Desai RA, Mazure CM, McKee SA: The relationship of dysthymia, minor depression, and gender to changes in smoking for current and former smokers: Longitudinal evaluation in the U.S. population. Drug Alcohol Depend. 2012, 127 (1-3): 170-176.

  101. 101.

    Glynn SM, Sussman S: Why patients smoke. Hosp Community Psychiatry. 1990, 41 (9): 1027-1028.

  102. 102.

    Malhi GS, Berk M: Does dopamine dysfunction drive depression?. Acta Psychiatr Scand. 2007, 433: 116-124.

  103. 103.

    Nunes SO, Vargas HO, Brum J, Prado E, Vargas MM, de Castro MR, Dodd S, Berk M: A comparison of inflammatory markers in depressed and nondepressed smokers. Nicotine Tob Res. 2012, 14 (5): 540-546. 10.1093/ntr/ntr247.

  104. 104.

    Bandiera FC, Arheart KL, Caban-Martinez AJ, Fleming LE, McCollister K, Dietz NA, Leblanc WG, Davila EP, Lewis JE, Serdar B, Lee DJ: Secondhand smoke exposure and depressive symptoms. Psychosom Med. 2010, 72 (1): 68-72. 10.1097/PSY.0b013e3181c6c8b5.

  105. 105.

    Nehlig A, Daval JL, Debry G: Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev. 1992, 17 (2): 139-170. 10.1016/0165-0173(92)90012-B.

  106. 106.

    Lara DR: Caffeine, mental health, and psychiatric disorders. J Alzheimers Dis. 2010, 20 (Suppl 1): S239-S248.

  107. 107.

    Berk M, Plein H, Ferreira D, Jersky B: Blunted adenosine A2a receptor function in platelets in patients with major depression. Eur Neuropsychopharmacol. 2001, 11 (2): 183-186. 10.1016/S0924-977X(01)00074-8.

  108. 108.

    Vilarim MM, Rocha Araujo DM, Nardi AE: Caffeine challenge test and panic disorder: a systematic literature review. Expert Rev Neurother. 2011, 11 (8): 1185-1195. 10.1586/ern.11.83.

  109. 109.

    Lucas M, Mirzaei F, Pan A, Okereke OI, Willett WC, O’Reilly EJ, Koenen K, Ascherio A: Coffee, caffeine, and risk of depression among women. Arch Intern Med. 2011, 171 (17): 1571-1578. 10.1001/archinternmed.2011.393.

  110. 110.

    Broderick P, Benjamin AB: Caffeine and psychiatric symptoms: a review. J Okla State Med Assoc. 2004, 97 (12): 538-542.

  111. 111.

    Rizkallah E, Bélanger M, Stavro K, Dussault M, Pampoulova T, Chiasson J, Potvin S: Could the use of energy drinks induce manic or depressive relapse among abstinent substance use disorder patients with comorbid bipolar spectrum disorder?. Bipolar Disord. 2011, 13 (5–6): 578-580.

  112. 112.

    Burrows T, Pursey K, Neve M, Stanwell P: What are the health implications associated with the consumption of energy drinks? A systematic review. Nutr Rev. 2013, 71 (3): 135-148. 10.1111/nure.12005.

  113. 113.

    Sepkowitz K: Energy drinks and caffeine-related adverse effects. JAMA. 2013, 309 (3): 243-244. 10.1001/jama.2012.173526.

  114. 114.

    McClung CA: Circadian rhythms and mood regulation: insights from pre-clinical models. Eur Neuropsychopharmacol. 2011, 21 (Suppl 4): S683-S693.

  115. 115.

    Monteleone P, Martiadis V, Maj M: Circadian rhythms and treatment implications in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35 (7): 1569-1574. 10.1016/j.pnpbp.2010.07.028.

  116. 116.

    Roth T, Roehrs T: Insomnia: epidemiology, characteristics, and consequences. Clin Cornerstone. 2003, 5 (3): 5-15. 10.1016/S1098-3597(03)90031-7.

  117. 117.

    van Mill JG, Hoogendijk WJ, Vogelzangs N, van Dyck R, Penninx BW: Insomnia and sleep duration in a large cohort of patients with major depressive disorder and anxiety disorders. J Clin Psychiatry. 2010, 71 (3): 239-246. 10.4088/JCP.09m05218gry.

  118. 118.

    Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, Lombardo C, Riemann D: Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011, 135 (1–3): 10-19.

  119. 119.

    Grandner MA, Jackson NJ, Pak VM, Gehrman PR: Sleep disturbance is associated with cardiovascular and metabolic disorders. J Sleep Res. 2012, 21 (4): 427-433. 10.1111/j.1365-2869.2011.00990.x.

  120. 120.

    Riemann D, Spiegelhalder K, Espie C, Pollmacher T, Leger D, Bassetti C, van Someren E: Chronic insomnia: clinical and research challenges–an agenda. Pharmacopsychiatry. 2011, 44 (1): 1-14.

  121. 121.

    Merrill RM, Aldana SG, Greenlaw RL, Diehl HA, Salberg A: The effects of an intensive lifestyle modification program on sleep and stress disorders. J Nutr Health Aging. 2007, 11 (3): 242-248.

  122. 122.

    Ibarra-Rovillard MS, Kuiper NA: Social support and social negativity findings in depression: perceived responsiveness to basic psychological needs. Clin Psychol Rev. 2011, 31 (3): 342-352. 10.1016/j.cpr.2011.01.005.

  123. 123.

    Stafford M, McMunn A, Zaninotto P, Nazroo J: Positive and negative exchanges in social relationships as predictors of depression: evidence from the English Longitudinal Study of Aging. J Aging Health. 2011, 23 (4): 607-628. 10.1177/0898264310392992.

  124. 124.

    Kouvonen A, De Vogli R, Stafford M, Shipley MJ, Marmot MG, Cox T, Vahtera J, Vaananen A, Heponiemi T, Singh-Manoux A, Kivimäki M: Social support and the likelihood of maintaining and improving levels of physical activity: the Whitehall II study. Eur J Public Health. 2012, 22 (4): 514-518. 10.1093/eurpub/ckr091.

  125. 125.

    Street G, James R, Cutt H: The relationship between organised physical recreation and mental health. Health Promot J Austr. 2007, 18 (3): 236-239.

  126. 126.

    Chan MF, Wong ZY, Thayala NV: The effectiveness of music listening in reducing depressive symptoms in adults: a systematic review. Complement Ther Med. 2011, 19 (6): 332-348. 10.1016/j.ctim.2011.08.003.

  127. 127.

    Jorm AF, Morgan AJ, Hetrick SE: Relaxation for depression. Cochrane Database Syst Rev. 2008, 4: CD007142

  128. 128.

    Lee AC, Maheswaran R: The health benefits of urban green spaces: a review of the evidence. J Public Health (Oxf). 2011, 33 (2): 212-222. 10.1093/pubmed/fdq068.

  129. 129.

    Annerstedt M, Wahrborg P: Nature-assisted therapy: systematic review of controlled and observational studies. Scand J Public Health. 2011, 39 (4): 371-388. 10.1177/1403494810396400.

  130. 130.

    Barton J, Pretty J: What is the best dose of nature and green exercise for improving mental health? A multi-study analysis. Environ Sci Technol. 2010, 44 (10): 3947-3955. 10.1021/es903183r.

  131. 131.

    Hahn IH, Grynderup MB, Dalsgaard SB, Thomsen JF, Hansen AM, Kaergaard A, Kaerlev L, Mors O, Rugulies R, Mikkelsen S, Bonde JP, Kolstad HA: Does outdoor work during the winter season protect against depression and mood difficulties?. Scand J Work Environ Health. 2011, 37 (5): 446-449. 10.5271/sjweh.3155.

  132. 132.

    Radua J, Pertusa A, Cardoner N: Climatic relationships with specific clinical subtypes of depression. Psychiatry Res. 2010, 175 (3): 217-220. 10.1016/j.psychres.2008.10.025.

  133. 133.

    Berk M, Sanders KM, Pasco JA, Jacka FN, Williams LJ, Hayles AL, Dodd S: Vitamin D deficiency may play a role in depression. Med Hypotheses. 2007, 69 (6): 1316-1319. 10.1016/j.mehy.2007.04.001.

  134. 134.

    Knippenberg S, Damoiseaux J, Bol Y, Hupperts R, Taylor BV, Ponsonby AL, Dwyer T, Simpson S, van der Mei IA: Higher levels of reported sun exposure, and not vitamin D status, are associated with less depressive symptoms and fatigue in multiple sclerosis. Acta Neurol Scand. 2013, 129 (2): 123-131.

  135. 135.

    Sanders KM, Stuart AL, Williamson EJ, Jacka FN, Dodd S, Nicholson G, Berk M: Annual high-dose vitamin D3 and mental well-being: randomised controlled trial. Br J Psychiatry. 2011, 198 (5): 357-364. 10.1192/bjp.bp.110.087544.

  136. 136.

    Genc S, Zadeoglulari Z, Fuss SH, Genc K: The adverse effects of air pollution on the nervous system. J Toxicol. 2012, 2012: 782462-

  137. 137.

    Fonken LK, Xu X, Weil ZM, Chen G, Sun Q, Rajagopalan S, Nelson RJ: Air pollution impairs cognition, provokes depressive-like behaviors and alters hippocampal cytokine expression and morphology. Mol Psychiatry. 2011, 16 (10): 987-995, 973. 10.1038/mp.2011.76.

  138. 138.

    Berget B, Braastad BO: Animal-assisted therapy with farm animals for persons with psychiatric disorders. Ann Ist Super Sanita. 2011, 47 (4): 384-390.

  139. 139.

    Moretti F, De Ronchi D, Bernabei V, Marchetti L, Ferrari B, Forlani C, Negretti F, Sacchetti C, Atti AR: Pet therapy in elderly patients with mental illness. Psychogeriatrics. 2011, 11 (2): 125-129. 10.1111/j.1479-8301.2010.00329.x.

  140. 140.

    Prochaska J, Butterworth S, Redding C, Burden V, Perrin N, Leo M, Flaherty-Robb M, Prochaska J: Initial efficacy of MI, TTM tailoring and HRI’s with multiple behaviors for employee health promotion. Prev Med. 2008, 46 (3): 226-231. 10.1016/j.ypmed.2007.11.007.

  141. 141.

    Ross JA, Kasum CM: Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr. 2002, 22: 19-34. 10.1146/annurev.nutr.22.111401.144957.

  142. 142.

    Howes MJ, Perry E: The role of phytochemicals in the treatment and prevention of dementia. Drugs Aging. 2011, 28 (6): 439-468. 10.2165/11591310-000000000-00000.

  143. 143.

    Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO: Exercise treatment for depression: efficacy and dose response. Am J Prev Med. 2005, 28 (1): 1-8. 10.1016/j.amepre.2004.09.003.

  144. 144.

    Singh NA, Stravinos TM, Scarbek Y, Galambos G, Liber C, Singh MAF: A randomized controlled trial of high versus low intensity weight training versus general practitioner care for clinical depression in older adults. J Gerontol A Biol Sci Med Sci. 2005, 60A (6): 768-776.

  145. 145.

    Khan NA, Hemmelgarn B, Herman RJ, Bell CM, Mahon JL, Leiter LA, Rabkin SW, Hill MD, Padwal R, Touyz RM, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Moe G, Prasad R, Arnold MO, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, DeChamplain J, Pylypchuk G, Petrella R, et al: The 2009 Canadian hypertension education program recommendations for the management of hypertension: part 2–therapy. Can J Cardiol. 2009, 25 (5): 287-298. 10.1016/S0828-282X(09)70492-1.

  146. 146.

    Daley A: Exercise and depression: a review of reviews. J Clin Psychol Med Settings. 2008, 15 (2): 140-147. 10.1007/s10880-008-9105-z.

  147. 147.

    Worthington J, Fava M, Agustin C, Alpert J, Nierenberg AA, Pava JA, Rosenbaum JF: Consumption of alcohol, nicotine, and caffeine among depressed outpatients. Relationship with response to treatment. Psychosomatics. 1996, 37 (6): 518-522. 10.1016/S0033-3182(96)71515-3.

  148. 148.

    Rae AM, Joyce PR, Luty SE, Mulder RT: The effect of a history of alcohol dependence in adult major depression. J Affect Disord. 2002, 70 (3): 281-290. 10.1016/S0165-0327(01)00365-2.

  149. 149.

    Baker AL, Thornton LK, Hiles S, Hides L, Lubman DI: Psychological interventions for alcohol misuse among people with co-occurring depression or anxiety disorders: a systematic review. J Affect Disord. 2012, 139 (3): 217-229. 10.1016/j.jad.2011.08.004.

  150. 150.

    Baker AL, Kavanagh DJ, Kay-Lambkin FJ, Hunt SA, Lewin TJ, Carr VJ, Connolly J: Randomized controlled trial of cognitive-behavioural therapy for coexisting depression and alcohol problems: short-term outcome. Addiction. 2010, 105 (1): 87-99. 10.1111/j.1360-0443.2009.02757.x.

  151. 151.

    Berk M: Should we be targeting smoking as a routine intervention?. Acta Neuropsychiatr. 2007, 19: 131-132. 10.1111/j.1601-5215.2007.00199.x.

  152. 152.

    Bernard P, Ninot G, Guillaume S, Fond G, Courtet P, Christine Picot M, Quantin X: Physical activity as a protective factor in relapse following smoking cessation in participants with a depressive disorder. Am J Addict. 2012, 21 (4): 348-355. 10.1111/j.1521-0391.2012.00242.x.

  153. 153.

    Hughes JR: Depression during tobacco abstinence. Nicotine Tob Res. 2007, 9 (4): 443-446. 10.1080/14622200701243185.

  154. 154.

    Aversa LH, Stoddard JA, Doran NM, Au S, Chow B, McFall M, Saxon A, Baker DG: PTSD and depression as predictors of physical health-related quality of life in tobacco-dependent veterans. J Psychosom Res. 2012, 73 (3): 185-190. 10.1016/j.jpsychores.2012.06.010.

  155. 155.

    Stepanski EJ, Wyatt JK: Use of sleep hygiene in the treatment of insomnia. Sleep Med Rev. 2003, 7 (3): 215-225. 10.1053/smrv.2001.0246.

  156. 156.

    Coogan AN, Thome J: Chronotherapeutics and psychiatry: setting the clock to relieve the symptoms. World J Biol Psychiatry. 2011, 12 (Suppl 1): 40-43.

  157. 157.

    Lambert GW, Reid C, Kaye DM, Jennings GL, Esler MD: Effect of sunlight and season on serotonin turnover in the brain. Lancet. 2002, 360 (9348): 1840-1842. 10.1016/S0140-6736(02)11737-5.

  158. 158.

    Riediker M, Koren HS: The importance of environmental exposures to physical, mental and social well-being. Int J Hyg Environ Health. 2004, 207 (3): 193-201. 10.1078/1438-4639-00284.

  159. 159.

    O’Neil A, Hawkes AL, Chan B, Sanderson K, Forbes A, Hollingsworth B, Atherton J, Hare DL, Jelinek M, Eadie K, Taylor CB, Oldenburg B: A randomised, feasibility trial of a tele-health intervention for acute coronary syndrome patients with depression (‘MoodCare’): study protocol. BMC Cardiovasc Disord. 2011, 11: 8-10.1186/1471-2261-11-8.

  160. 160.

    Garcia-Toro M, Ibarra O, Gili M, Serrano MJ, Olivan B, Vicens E, Roca M: Four hygienic-dietary recommendations as add-on treatment in depression: a randomized-controlled trial. J Affect Disord. 2012, 140 (2): 200-203. 10.1016/j.jad.2012.03.031.

Pre-publication history

  1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-244X/14/107/prepub

Download references

Acknowledgements

This paper is dedicated to the late Professor Issy Schweitzer, who was the archetypal manifestation of the principles contained within this manuscript. Drs J. Sarris is funded by a CR Roper Fellowship. A O’Neil is funded by National Health & Medical Research Council (NHMRC) Research Fellowship (AO: 1052865).

Author information

Affiliations

  1. Department of Psychiatry, The University of Melbourne, 2 Salisbury Street, Richmond, 3121, Victoria, Australia
    • Jerome Sarris
    • , Isaac Schweitzer
    •  & Michael Berk
  2. Centre for Human Psychopharmacology, Swinburne University of Technology, Melbourne, Australia
    • Jerome Sarris
  3. School of Medicine, Deakin University, Geelong, Australia
    • Adrienne O’Neil
    • , Carolyn E Coulson
    •  & Michael Berk
  4. School of Public Health & Preventive Medicine, Monash University, Melbourne, Australia
    • Adrienne O’Neil
  5. Florey Institute for Neuroscience and Mental Health, Parkville, Australia
    • Michael Berk
  6. Orygen Youth Health Research Institute, Parkville, Australia
    • Michael Berk
Authors
  1. Jerome Sarris
    View author publications
    You can also search for this author in
  2. Adrienne O’Neil
    View author publications
    You can also search for this author in
  3. Carolyn E Coulson
    View author publications
    You can also search for this author in
  4. Isaac Schweitzer
    View author publications
    You can also search for this author in
  5. Michael Berk
    View author publications
    You can also search for this author in

Corresponding author

Correspondence to Jerome Sarris.

Additional information

Competing interest

No authors note any direct competing interest.

Authors’ contribution

All authors contributed content and editing to the manuscript. All authors read and approved the final manuscript.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

Reprints and Permissions

About this article

Cite this article

Sarris, J., O’Neil, A., Coulson, C.E. et al. Lifestyle medicine for depression. BMC Psychiatry 14, 107 (2014). https://doi.org/10.1186/1471-244X-14-107

Download citation

Keywords

  • Lifestyle
  • Depression
  • Exercise
  • Diet
  • Smoking
  • Alcohol
  • Prevention
  • Treatment

BMC Psychiatry

ISSN: 1471-244X

Contact us